LACOSAMIDE (Breckenridge Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the LACOSAMIDE drug offered from Breckenridge Pharmaceutical, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Breckenridge Pharmaceutical, Inc.
NON-PROPRIETARY NAME: LACOSAMIDE
SUBSTANCE NAME: LACOSAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-06-15
END MARKETING DATE: 0000-00-00


LACOSAMIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLACOSAMIDE from Breckenridge Pharmaceutical, Inc.
LABELER NAME: Breckenridge Pharmaceutical, Inc.
DEA SCHEDULE: CV
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2016-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51991-348_b4c6bc3b-3d9a-4518-94f1-d620bf5c3e8c
PRODUCT NDC: 51991-348
APPLICATION NUMBER: ANDA204921

Other LACOSAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals of New York, LLCLacosamide
Breckenridge Pharmaceutical, Inc.LACOSAMIDE
Natco Pharma LimitedLacosamide
Physicians Total Care, Inc.Vimpat
REMEDYREPACK INC.Vimpat
UCB, Inc.Vimpat